[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Filana Therapeutics Inc (FLNA)

Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Filana Therapeutics Inc 6801 N. CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 USA

www.filanatx.com Employees: 17 P: 512-501-2444

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Filana Therapeutics Inc. is a biotechnology company focused on developing novel medicines to modulate the filamin A protein for the treatment of central nervous system disorders, such as Tuberous Sclerosis Complex related epilepsy and other diseases associated with dysregulation or overexpression of filamin A. Filana Therapeutics Inc., formerly known as Cassava Sciences, Inc., is based in AUSTIN, Texas.

Key Statistics

Overview:

Market Capitalization, $K 44,926
Enterprise Value, $K -50,574
Shares Outstanding, K 48,308
Float, K 46,086
% Float 95.40%
Short Interest, K 6,461
Short Float 13.37%
Days to Cover 20.71
Short Volume Ratio 0.37
% of Insider Shareholders 4.60%
% of Institutional Shareholders 38.05%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -90,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,600 K
EBIT, $ -45,970 K
EBITDA, $ -45,030 K

Growth:

1-Year Return -56.07%
3-Year Return -95.58%
5-Year Return -98.15%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -683.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 07/29/26
Next Earnings Date 11/11/26
Earnings Per Share ttm -0.87
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.750 on 12/13/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 05/10/17

FLNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.78%
Return-on-Assets % -36.74%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.73
Book Value/Share 1.32
Interest Coverage -0.32
60-Month Beta -0.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.